Aspirin Use and Cardiovascular Outcome in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Population‐Based Cohort Study

BACKGROUND: Aspirin is of uncertain benefit for primary prevention in patients with type 2 diabetes mellitus (T2D). We assessed whether primary prevention with aspirin is beneficial in patients with T2D and heart failure (HF). METHODS AND RESULTS: Data from The Health Improvement Network, a UK multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Abi Khalil, Charbel, Omar, Omar M., Al Suwaidi, Jassim, Taheri, Shahrad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404217/
https://www.ncbi.nlm.nih.gov/pubmed/30608202
http://dx.doi.org/10.1161/JAHA.118.010033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404217/
https://www.ncbi.nlm.nih.gov/pubmed/30608202
http://dx.doi.org/10.1161/JAHA.118.010033

Ejemplares similares